Innovita Biological Technology Co Ltd Class A 688253
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥34.02
- Day Range
- ¥33.38–34.68
- 52-Week Range
- ¥19.12–47.85
- Bid/Ask
- ¥34.31 / ¥34.35
- Market Cap
- ¥4.67 Bil
- Volume/Avg
- 1.3 Mil / 2.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 19.67
- Price/Sales
- 7.49
- Dividend Yield (Trailing)
- 1.16%
- Dividend Yield (Forward)
- 1.16%
- Total Yield
- 1.16%
Company Profile
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 439
- Website
- https://www.innovita.com.cn
Comparables
Valuation
|
Metric
|
688253
|
688068
|
000710
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.67 | — | — |
Price/Book Value | 2.35 | 0.71 | 1.33 |
Price/Sales | 7.49 | 4.84 | 2.27 |
Price/Cash Flow | 11.35 | 12.45 | 23.76 |
Price/Earnings
688253
688068
000710
Financial Strength
|
Metric
|
688253
|
688068
|
000710
|
|---|---|---|---|
Quick Ratio | 10.60 | 2.87 | 1.63 |
Current Ratio | 11.04 | 6.20 | 2.02 |
Interest Coverage | 1,693.02 | — | — |
Quick Ratio
688253
688068
000710
Profitability
|
Metric
|
688253
|
688068
|
000710
|
|---|---|---|---|
Return on Assets (Normalized) | 12.17% | −3.97% | −13.01% |
Return on Equity (Normalized) | 13.13% | −4.25% | −18.59% |
Return on Invested Capital (Normalized) | 12.68% | −5.10% | −15.87% |
Return on Assets
688253
688068
000710
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Nvjdgbdxs | Qyp | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Bcbdcxkr | Jjgtgv | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Mbxyvlrr | Vsspm | $118.7 Bil | |||
| Moderna Inc
MRNA
| Jqzbphz | Nsxhy | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Xcjwswkvc | Pxqyypd | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Spxglcv | Ywgf | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Szylpcxj | Pbxn | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Tcvtdvgh | Ppywbc | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Whxsdmnpr | Bry | $15.0 Bil | |||
| Incyte Corp
INCY
| Mnqlstj | Vzwkfjg | $13.5 Bil |